Comparison between alemtuzumab and antithymocyte globulin in reduced-intensity stem cell transplantation

被引：0
|
作者：
Kim, Y. [1 ]
Park, I. [1 ]
Yoon, S. [1 ]
Kim, S. [1 ]
Lee, H. [1 ]
Lee, Y. [1 ]
Kwon, K. [1 ]
Kim, J. [1 ]
Cheong, J. [1 ]
Min, Y. [1 ]
机构：
[1] Yonsei Univ, Coll Med, Seoul, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S210 / S211
页数：2
相关论文
共 50 条
  • [21] Antithymocyte Globulin in Reduced-Intensity Conditioning Allografting: Is the Benefit Simply in the Eyes of the Transplanter?
    Hamadani, Mehdi
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (03) : 292 - 294
  • [22] Current indications for reduced-intensity allogeneic stem cell transplantation
    Haddad, N
    Rowe, JM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2004, 17 (03) : 377 - 386
  • [23] Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis
    Cooper, N
    Rao, K
    Gilmour, K
    Hadad, L
    Adams, S
    Cale, C
    Davies, G
    Webb, D
    Veys, P
    Amrolia, P
    BLOOD, 2006, 107 (03) : 1233 - 1236
  • [24] Reduced-intensity allogeneic haematopoietic stem cell transplantation for lymphomas
    Bonifazi, F.
    Colaci, E.
    Bandini, G.
    Arpinati, M.
    Stanzani, M.
    Usai, S.
    Tazzari, P.
    Bontadini, A.
    Ricci, F.
    Dan, E.
    Taioli, S.
    Fina, M. P.
    Pellegrini, C.
    Zinzani, P.
    Baccarani, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S216 - S217
  • [25] Double reduced-intensity allogeneic haematopoietic stem cell transplantation
    Bay, J. -O.
    Cabrespine-Faugeras, A.
    Faucher, C.
    Tabrizi, R.
    Bordigoni, P.
    Bilger, K.
    Jouet, J. P.
    Renaud, M.
    Mialou, V.
    Robin, M.
    Kuentz, M.
    Chevallier, P.
    Dhedin, N.
    Huynh, A.
    Garban, F.
    Witz, F.
    Buzyn, A.
    De Revel, T.
    Galambrun, C.
    Deconnick, E.
    Contentin, N.
    Francois, S.
    Blaise, D.
    Michallet, M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S283 - S283
  • [26] Antifungal prophylaxis following reduced-intensity stem cell transplantation
    Kami, M.
    Murashige, N.
    Tanaka, Y.
    Narimatsu, H.
    TRANSPLANT INFECTIOUS DISEASE, 2006, 8 (04) : 190 - 202
  • [27] Standard and reduced-intensity allogeneic haematopoietic stem cell transplantation
    Michallet, M.
    Le, Q. -H.
    Dreger, P.
    Sobh, M.
    Niederwieser, D.
    Koza, V.
    Ruutu, T.
    Russell, N.
    Verdonck, L.
    Milligan, D.
    Dedhin, N.
    Kozak, T.
    Boogaerts, M.
    Finke, J.
    Tedone, N.
    Van Biezen, A.
    Brand, R.
    De Witte, T.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S50 - S50
  • [28] Comparison between antithymocyte globulin and alemtuzumab and the possible impact of KIR-ligand mismatch after dose-reduced conditioning and unrelated stem cell transplantation in patients with multiple myeloma
    Kröger, N
    Shaw, B
    Iacobelli, S
    Zabelina, T
    Peggs, K
    Shimoni, A
    Nagler, A
    Binder, T
    Eiermann, T
    Madrigal, A
    Schwerdtfeger, R
    Kiehl, M
    Sayer, HG
    Beyer, J
    Bornhäuser, M
    Ayuk, F
    Zander, AR
    Marks, DI
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 631 - 643
  • [29] Impact of CD8+ T-cell dose on GvhD after antithymocyte globulin (ATG)-based reduced-intensity conditioning (RIC) for allogeneic stem cell transplantation
    Mohty, M
    Faucher, C
    Bagattini, S
    Bardou, V
    Bilger, K
    Gaugler, B
    Chabannon, C
    Ladaique, P
    Lemarie, C
    Vey, N
    Gastaut, JA
    Maraninchi, D
    Olive, D
    Blaise, D
    BONE MARROW TRANSPLANTATION, 2004, 33 : S181 - S181
  • [30] Full-intensity and reduced-intensity allogeneic stem cell transplantation in AML
    C F Craddock
    Bone Marrow Transplantation, 2008, 41 : 415 - 423
12345